Journal: (Dr Hoseingholizadeh)

PCSK9 inhibition with orally administered NNC0385-0434 in hypercholesterolaemia: a randomised, double-blind, placebo-controlled and active-controlled phase 2 trial.

Conference: (Dr Babazadeh)

hormone therapy of transsexual males and females.